Get the Stockscreener App
2.15
4.88%
0.10
After Hours:
2.18
0.03
+1.40%
Annexon Inc stock is traded at $2.15, with a volume of 1.80M.
It is up +4.88% in the last 24 hours and down -15.02% over the past month.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
See More
Previous Close:
$2.05
Open:
$2.05
24h Volume:
1.80M
Relative Volume:
1.25
Market Cap:
$236.26M
Revenue:
-
Net Income/Loss:
$-134.24M
P/E Ratio:
-1.2147
EPS:
-1.77
Net Cash Flow:
$-121.34M
1W Performance:
+1.42%
1M Performance:
-15.02%
6M Performance:
-12.96%
1Y Performance:
-61.54%
1-Day Range:
$2.04
$2.17
1-Week Range:
$2.03
$2.17
52-Week Range:
$1.285
$7.85
Annexon Inc Stock (ANNX) Company Profile
Name
Annexon Inc
Sector
Industry
Phone
(650)-822-5500
Address
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
2.15 | 227.47M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-21-23 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-30-23 | Initiated | Wells Fargo | Overweight |
| May-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| May-25-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-16-22 | Initiated | Jefferies | Buy |
| Sep-09-22 | Initiated | BTIG Research | Buy |
| Nov-30-21 | Initiated | H.C. Wainwright | Buy |
| Sep-23-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-26-21 | Initiated | Needham | Buy |
| Aug-18-20 | Initiated | BofA Securities | Buy |
| Aug-18-20 | Initiated | Cowen | Outperform |
| Aug-18-20 | Initiated | JP Morgan | Overweight |
View All
Annexon Inc Stock (ANNX) Latest News
Will breakout in Annexon Inc. lead to full recoveryTrade Volume Summary & Growth Focused Entry Point Reports - Newser
Will Annexon Inc. benefit from macro trendsTrade Risk Assessment & High Conviction Buy Zone Alerts - Newser
Volatility clustering patterns for Annexon Inc.Market Growth Review & Community Consensus Trade Signals - Newser
Will Annexon Inc. benefit from current market trendsWeekly Investment Report & Weekly High Return Forecasts - khodrobank.com
Custom watchlist performance reports with Annexon Inc.Weekly Investment Report & Verified Entry Point Signals - Newser
Will Annexon Inc. stock go up soonWeekly Stock Recap & Accurate Entry/Exit Alerts - Newser
Analyzing recovery setups for Annexon Inc. investorsTrade Entry Summary & Safe Entry Point Identification - Newser
Applying Wyckoff theory to Annexon Inc. stockJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - Newser
What machine learning models say about Annexon Inc.July 2025 Outlook & Weekly Top Gainers Alerts - Newser
How to build a dashboard for Annexon Inc. stockJuly 2025 Volume & Free Technical Confirmation Trade Alerts - Newser
What is Annexon Inc. s 5 year growth outlookPortfolio Return Summary & High Conviction Buy Zone Picks - khodrobank.com
Regression analysis insights on Annexon Inc. performanceQuarterly Earnings Summary & Daily Oversold Bounce Ideas - Newser
What moving averages say about Annexon Inc.2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - Newser
Backtesting results for Annexon Inc. trading strategiesQuarterly Profit Review & Step-by-Step Trade Execution Guides - Newser
Visualizing Annexon Inc. stock with heatmapsWeekly Trend Summary & Free Expert Approved Momentum Trade Ideas - Newser
Earnings visualization tools for Annexon Inc.Fed Meeting & Risk Managed Investment Strategies - Newser
What momentum shifts mean for Annexon Inc.Trend Reversal & Daily Technical Forecast Reports - Newser
What technical models suggest about Annexon Inc.’s comeback2025 Sector Review & Fast Exit/Entry Strategy Plans - Newser
Is Annexon Inc. affected by consumer sentiment2025 Retail Activity & Daily Entry Point Trade Alerts - khodrobank.com
Will Annexon Inc. see short term momentumQuarterly Portfolio Report & Trade Opportunity Analysis - Newser
Does Annexon Inc. fit your quant trading model2025 Winners & Losers & Low Risk Investment Opportunities - Newser
Is Annexon Inc. being accumulated by smart moneyJuly 2025 Levels & Free Weekly Watchlist of Top Performers - khodrobank.com
Forecasting Annexon Inc. price range with options dataWeekly Profit Summary & Community Verified Watchlist Alerts - Newser
Can trapped investors hope for a rebound in Annexon Inc.July 2025 Snapshot & Safe Capital Allocation Plans - Newser
How Annexon Inc. stock performs during market volatilityBull Run & Accurate Trade Setup Notifications - Newser
Is Annexon Inc. stock trending bullishMarket Risk Analysis & Smart Swing Trading Alerts - khodrobank.com
Real time breakdown of Annexon Inc. stock performanceAnalyst Downgrade & Weekly Setup with ROI Potential - Newser
Annexon Inc. stock outlook for YEARJuly 2025 Chart Watch & Free Reliable Trade Execution Plans - Newser
Analyzing Annexon Inc. with risk reward ratio charts2025 Historical Comparison & Expert Verified Stock Movement Alerts - Newser
Long term hold vs stop loss in Annexon Inc.Quarterly Trade Report & Expert Verified Stock Movement Alerts - Newser
Can swing trading help recover from Annexon Inc. lossesEarnings Overview Report & Weekly Watchlist of Top Performers - Newser
Will Annexon Inc. announce a stock splitBreakout Watch & Fast Gain Swing Alerts - khodrobank.com
Is Annexon Inc. benefiting from innovation trends2025 Stock Rankings & Fast Entry High Yield Stock Tips - khodrobank.com
Is Annexon Inc. stock risky to hold nowBond Market & Fast Moving Stock Trade Plans - khodrobank.com
Stop Loss: Does Annexon Inc. stock benefit from AI growth2025 Top Gainers & Consistent Return Strategy Ideas - khodrobank.com
Is Annexon Inc. subject to activist investor interestJuly 2025 Trends & Daily Stock Trend Reports - khodrobank.com
How hedge fund analytics apply to Annexon Inc. stockJuly 2025 Gainers & Community Supported Trade Ideas - Newser
Published on: 2025-08-31 21:46:03 - Newser
Custom strategy builders for tracking Annexon Inc.July 2025 Retail & Accurate Trade Setup Notifications - Newser
Is Annexon Inc. stock reversal real or fakeJuly 2025 Levels & Real-Time Stock Entry Alerts - Newser
Can Annexon Inc. rally from current levelsQuarterly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Multi factor analysis applied to Annexon Inc.July 2025 Volume & AI Driven Price Forecasts - Newser
Annexon Inc Stock (ANNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Annexon Inc Stock (ANNX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER |
Jul 14 '25 |
Sale |
2.58 |
1,116 |
2,879 |
105,084 |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER |
Jul 14 '25 |
Sale |
2.58 |
1,117 |
2,882 |
121,616 |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER |
Jul 14 '25 |
Sale |
2.61 |
853 |
2,226 |
130,689 |
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):